Ascendis Pharma's Series D Round

Ascendis Pharma raised a round of funding on December 01, 2014.

Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that addr…

Articles about Ascendis Pharma's Series D Round: